GDS Wealth Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.2M Buy
97,056
+9,421
+11% +$1.73M 0.86% 54
2026
Q1
$16.5M Buy
87,635
+5,530
+7% +$1.17M 0.99% 43
2025
Q4
$16.3M Buy
82,105
+2,030
+3% +$410K 1.02% 41
2025
Q3
$16.3M Buy
80,075
+4,956
+7% +$879K 1.07% 38
2025
Q2
$13.2M Buy
75,119
+10,788
+17% +$1.62M 0.96% 43
2025
Q1
$8.65M Buy
64,331
+25,735
+67% +$3.39M 0.74% 44
2024
Q4
$4.87M Buy
38,596
+35,538
+1,162% +$5.28M 0.44% 50
2024
Q3
$508K Buy
+3,058
New +$462K 0.05% 96

Other funds holding THC

GDS Wealth Management's THC Position: Q2 2026 in Review

GDS Wealth Management increased its Tenet Healthcare (THC) stake by 11% in Q2 2026, buying an estimated $1.73M and bringing the position to 97,056 shares worth $18.2M. The position accounts for 0.86% of the portfolio, ranked #54.

GDS Wealth Management first reported a position in THC in Q3 2024 and has held it in 8 quarters since. 678 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • GDS Wealth Management held 97,056 shares of Tenet Healthcare worth $18.2M as of Q2 2026.
  • GDS Wealth Management bought 9,421 Tenet Healthcare shares in Q2 2026, an estimated $1.73M.
  • Tenet Healthcare made up 0.86% of GDS Wealth Management's portfolio in Q2 2026, its #54 holding.
  • GDS Wealth Management first reported a position in Tenet Healthcare in Q3 2024 and has held it in 8 quarters since.
  • 678 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on GDS Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.